Additionally, the prognosis of macular edema may help clinicians evaluate renal function, investigators reported ...
Older patients with diabetic macular edema have a weaker response to anti-VEGF treatment, according to a presentation at ...
Combined company expected to trade on Nasdaq under “KLRS” after closingPALO ALTO, Calif. and LEXINGTON, Mass., March 12, 2025 ...
In addition to comparable BCVA levels, the researchers concluded that the PDS implant “provides effective, durable, and ...
Susvimo is now available to U.S. retina specialists and their patients with DME. “Susvimo presents a unique, convenient treatment alternative to routine eye injections for people with a ...
Privately-held Ashvattha Therapeutics, a Californian firm advancing a new class of nanomedicine therapeutics that traverse ...
Hosted on MSN1mon
DURAVYU shows promise in Phase 2 trial for eye diseaseDME is a significant public health concern ... EyePoint has also appointed Dr. Reginald J. Sanders, a renowned retina specialist, to its Board of Directors. Analysts from Citi have initiated ...
“The promising results for patients with DME and nAMD suggest that faricimab may also be efficacious in other retinal vascular diseases,” they wrote. Due to the multifactorial pathogenesis of ...
Announces several updates to enhance and accelerate AXPAXLI registrational program in wet AMD, potentially supporting label flexibility of 6-12 ...
DME can occur at any stage of DR as the blood vessels in the retina become increasingly fragile and leak fluid, potentially causing visual impairment. In the U.S., approximately 1.5 million ...
4-6 Susvimo is now available to US retina specialists and their patients with DME. “Susvimo presents a unique, convenient treatment alternative to routine eye injections for people with a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback